Clinical and Biological Effects of Combined CD27 and CD20 Antibody Therapy in Relapsed/Refractory B-Cell Lymphoma: The Riva Trial

SH Lim, HS Sow, C Wignall, K Mercer, J Caddy, C Boxall, K Thorne, J Northey, L Stanton, Z Konn, K Fines, PG Medd, A Coleman, L Nunn, R Lown, P Mckay, W Osborne, K Linton, GP Collins, AJ GentlesM Rose-Zerilli, G Griffiths

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Number of pages5
JournalBlood
Volume138
DOIs
Publication statusPublished - 23 Nov 2021

Cite this